Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GREENWICH LIFESCIENCES, INC. (GLSI)

  • Technical Exchange News
  • April 24, 2026, 02:30 UTC
  • 0
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

GLSI attributes changed

  • Technical Exchange News
  • April 24, 2026, 02:30 UTC
  • 2
  • 0 comments

GLSI attributes changed: Attr: Fin_status N -> E;

Comment Full text

GITS attributes changed

  • Technical Exchange News
  • April 24, 2026, 02:30 UTC
  • 1
  • 0 comments

GITS attributes changed: Attr: Fin_status N -> E;

Comment Full text

CHAR attributes changed

  • Technical Exchange News
  • April 24, 2026, 02:29 UTC
  • 1
  • 0 comments

CHAR attributes changed: Attr: Fin_status N -> E;

Comment Full text

CHARU attributes changed

  • Technical Exchange News
  • April 24, 2026, 02:29 UTC
  • 1
  • 0 comments

CHARU attributes changed: Attr: Fin_status N -> E;

Comment Full text

CHARR attributes changed

  • Technical Exchange News
  • April 24, 2026, 02:29 UTC
  • 1
  • 0 comments

CHARR attributes changed: Attr: Fin_status N -> E;

Comment Full text

BKYI attributes changed

  • Technical Exchange News
  • April 24, 2026, 02:29 UTC
  • 2
  • 0 comments

BKYI attributes changed: Attr: Fin_status D -> H;

Comment Full text

AGAE attributes changed

  • Technical Exchange News
  • April 24, 2026, 02:29 UTC
  • 0
  • 0 comments

AGAE attributes changed: Attr: Fin_status D -> H;

Comment Full text

GREENWICH LIFESCIENCES, INC. (GLSI)

  • Technical Exchange News
  • April 24, 2026, 01:39 UTC
  • 1
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Lakewood-Amedex Biotherapeutics Inc. - Common Stock (LABT)

  • Technical Exchange News
  • April 23, 2026, 12:57 UTC
  • 2
  • 0 comments

Lakewood-Amedex Biotherapeutics Inc. - Common Stock (LABT) was added to the exchange traded list on NASDAQ

Comment Full text
  • Previous
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next

Search

News categories

  • Technical Exchange News(12220)
  • Event(6113)
  • SEC News(262590)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(153946)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin